Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron J Hoogwerf

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cleveland Clinic Journal of Medicine|January 3, 2023
Statins may increase diabetes, but benefit still outweighs riskByron J Hoogwerf
Cleveland Clinic Journal of Medicine|February 5, 2020
Type of diabetes mellitus: Does it matter to the clinician?Byron J Hoogwerf
Cleveland Clinic Journal of Medicine|October 23, 2008
Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORDByron J Hoogwerf, ,
Cleveland Clinic Journal of Medicine|December 1, 2025
LADA: A case for starting insulin therapy at diagnosisByron J Hoogwerf
Cleveland Clinic Journal of Medicine|May 20, 2006
Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitusByron J Hoogwerf
Clinics in Geriatric Medicine|June 27, 2020
Hypoglycemia in Older PatientsByron J Hoogwerf
Diabetes Care|December 22, 2022
Prediabetes, Atrial Fibrillation, and Heart Failure: An Intersection of ComorbiditiesByron J Hoogwerf
The Journal of Laboratory and Clinical Medicine|January 31, 2006
HgbA1c and glucose control: we cannot play it straight with patientsByron J Hoogwerf
Cleveland Clinic Journal of Medicine|October 14, 2004
A DASH-like diet can decrease cardiovascular risk, but barriers to implementation existByron J Hoogwerf
Cleveland Clinic Journal of Medicine|March 31, 2006
Perioperative management of diabetes mellitus: how should we act on the limited evidence?Byron J Hoogwerf
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cleveland Clinic Journal of Medicine|January 3, 2023
Statins may increase diabetes, but benefit still outweighs riskByron J Hoogwerf
Cleveland Clinic Journal of Medicine|February 5, 2020
Type of diabetes mellitus: Does it matter to the clinician?Byron J Hoogwerf
Cleveland Clinic Journal of Medicine|October 23, 2008
Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORDByron J Hoogwerf, ,
Cleveland Clinic Journal of Medicine|December 1, 2025
LADA: A case for starting insulin therapy at diagnosisByron J Hoogwerf
Cleveland Clinic Journal of Medicine|May 20, 2006
Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitusByron J Hoogwerf
Clinics in Geriatric Medicine|June 27, 2020
Hypoglycemia in Older PatientsByron J Hoogwerf
Diabetes Care|December 22, 2022
Prediabetes, Atrial Fibrillation, and Heart Failure: An Intersection of ComorbiditiesByron J Hoogwerf
The Journal of Laboratory and Clinical Medicine|January 31, 2006
HgbA1c and glucose control: we cannot play it straight with patientsByron J Hoogwerf
Cleveland Clinic Journal of Medicine|October 14, 2004
A DASH-like diet can decrease cardiovascular risk, but barriers to implementation existByron J Hoogwerf
Cleveland Clinic Journal of Medicine|March 31, 2006
Perioperative management of diabetes mellitus: how should we act on the limited evidence?Byron J Hoogwerf
Pageof 8